1 completed, 1 recruiting, 1 terminated. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Aluminum: new trials by email Literature Review of Aluminum trials Research Report on Aluminum
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children OSP:rTTHc CCV 25 ㎍ with Aluminum phosphate, OSP:rTTHc CCV 25 ㎍ without Aluminum phosphate, Euvichol®-Plus - Cholera Vaccination | Phase 2 | Recruiting | International Vaccine Institute | 390 | 2026-01-13 | 2026-04-03 |
| Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas Aluminum, Tetanus toxoid - Granuloma, Aluminum Allergy | Not applicable | Completed | National Allergy Research Center, Denmark | 16 | 2022-09-13 | 2023-11-14 |
| Tepilta® Versus Oxetacaine, Antacids and Placebo oxetacaine, aluminium and magnesium hydroxide, oxetacaine, magnesium and aluminium hydroxide - Radiation-induced Oesophagitis | Phase 3 | Terminated | MEDA Pharma GmbH & Co. KG | 40 | 2011-04-01 | 2022-02-07 |
Dermatitis, Contact (1) · Granuloma (1) · Hypersensitivity (1)
International Vaccine Institute (1) · MEDA Pharma GmbH & Co. KG (1) · National Allergy Research Center, Denmark (1)
Austria (1) · Denmark (1) · Germany (1) · Kenya (1)
Frank Bruns, Dr. med. (1) · Julia Lynch, MD (1) · Lars Blom, PhD (1) · Ursula Petzold, PhD (1)
2009 (1)